13:39 EDT Tenax Therapeutics (TENX) trading halted, volatility trading pause
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TENX:
- Tenax Therapeutics Approves Officer Exculpation Amendment
- Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
- Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
- Tenax Therapeutics price target lowered to $15 from $16 at Guggenheim
- Tenax Therapeutics reports Q1 EPS (28c), consensus (41c)